Search
for
Sort by
Research 61–90 of 523
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Exploring the mechanism of Platycladi Cacumen in intervening androgenetic alopecia based on network pharmacology, molecular docking, and molecular dynamics simulation
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- Promoting axonal regeneration through exosomes: An update of recent findings on exosomal PTEN and mTOR modifiers
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays
- Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism
- Male Sex Hormones in Andrology Today
- The vitamin B5/coenzyme A axis: A target for immunomodulation?
- Protective Role of Nutritional Plants Containing Flavonoids in Hair Follicle Disruption: A Review
- Activation of mitochondrial aldehyde dehydrogenase 2 promotes hair growth in human hair follicles
- Udenafil Induces the Hair Growth Effect of Adipose-Derived Stem Cells
- Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment
- A Comprehensive Review of Mammalian Pigmentation: Paving the Way for Innovative Hair Colour-Changing Cosmetics
- Gender Differences in Cardiac Hypertrophy
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Dissecting the Impact of α-MSH-MC1R-cAMP Signaling on UVA-Induced Stress in Fibroblasts - Implications for Regulation of Cutaneous Photoaging
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
- New effects of caffeine on corticotropin‐releasing hormone (CRH)‐induced stress along the intrafollicular classical hypothalamic–pituitary–adrenal (HPA) axis (CRH‐R1/2, IP<sub>3</sub>‐R, ACTH, MC‐R2) and the neurogenic non‐HPA axis (substance P, p75<sup>NTR</sup>and TrkA) in<i>ex vivo</i>human male androgenetic scalp hair follicles
- Lipid signaling in keratinocytes: Lipin-1 plays a PArt
- From bench to babies – drug development for male subfertility
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- The role of WNT10B in physiology and disease: A 10-year update
- Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells
- Caffeine as an Active Molecule in Cosmetic Products for Hair Loss: Its Mechanisms of Action in the Context of Hair Physiology and Pathology
- Lysophospholipid Mediators in Health and Disease